C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent

Mark Woodward1, Ann Rumley, Gordon D O Lowe

  • 1Institute for International Health, University of Sydney, Australia. mwoodward@iih.usyd.edu.au

Insights

C-reactive protein (CRP) correlates with cardiovascular disease risk factors. While CRP is linked to prevalent cardiovascular disease, this association is largely explained by other risk factors, particularly fibrinogen, except for a residual effect in women.

Area of Science:

  • Biochemistry
  • Epidemiology
  • Cardiovascular Medicine

Background:

  • C-reactive protein (CRP) is a proposed cardiovascular disease (CVD) risk factor.
  • Its association with CVD is confounded by classical and hematological risk factors.

Purpose of the Study:

  • To investigate the correlation of high-sensitivity CRP with CVD risk factors.
  • To determine the association between CRP and prevalent CVD, considering confounders.

Main Methods:

  • High-sensitivity CRP assay on stored plasma samples from 414 men and 515 women (North Glasgow MONICA survey).
  • Correlations assessed with hematological variables, classical CVD risk factors, and prevalent CVD.
  • Statistical adjustment for classical risk factors and fibrinogen.

Main Results:

  • CRP correlated with age, oral contraceptive use, menopause, and most classical risk factors (excluding blood pressure).
  • CRP also correlated with interleukin-6, hematocrit, viscosity, red cell aggregation, white cell count, and coagulation factors (fibrinogen, FVII, FVIII, FIX).
  • CRP was associated with prevalent CVD in men and women, but this became non-significant after adjusting for classical risk factors and fibrinogen, with a residual independent effect noted in women.

Conclusions:

  • Correlations with classical and hematological risk factors explain a significant part of the CRP-CVD association.
  • A residual, independent effect of CRP on prevalent cardiovascular disease may exist in women.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...